Related references
Note: Only part of the references are listed.Marginal zone B cells acquire dendritic cell functions by trogocytosis
Patrick Schriek et al.
SCIENCE (2022)
Compstatins: the dawn of clinical C3-targeted complement inhibition
Christina Lamers et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Effects of the complement system on antibody formation and function: implications for transplantation
Arun Cumpelik et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2022)
C5a receptor antagonism coming of age for vascular pathology
Francois Marceau et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Ex vivo delivery of Mirococept: A dose-finding study in pig kidney after showing a low dose is insufficient to reduce delayed graft function in human kidney
Theodoros Kassimatis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Activation of final complement components after kidney transplantation as a marker of delayed graft function severity
Carlos E. Arias-Cabrales et al.
CLINICAL KIDNEY JOURNAL (2021)
Complement in ischaemia-reperfusion injury and transplantation
Mark C. Howard et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
A Novel Image Analysis Approach Reveals a Role for Complement Receptors 1 and 2 in Follicular Dendritic Cell Organization in Germinal Centers
Jessica C. Anania et al.
FRONTIERS IN IMMUNOLOGY (2021)
Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab
Austin G. Kulasekararaj et al.
BLOOD (2021)
Dynamic regulation of B cell complement signaling is integral to germinal center responses
Arun Cumpelik et al.
NATURE IMMUNOLOGY (2021)
Multiplex gene analysis reveals T-cell and antibody-mediated rejection-specific upregulation of complement in renal transplants
Eva Vonbrunn et al.
SCIENTIFIC REPORTS (2021)
Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis
Sigridur Sunna Aradottir et al.
FRONTIERS IN IMMUNOLOGY (2021)
Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471)
Jason A. Wiles et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials
Bernd Schroeppel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
l-Fucose prevention of renal ischaemia/reperfusion injury in Mice
Mark C. Howard et al.
FASEB JOURNAL (2020)
Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
Nello Mainolfi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells
Pooja Shivshankar et al.
FASEB JOURNAL (2020)
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
Richard A. Lafayette et al.
KIDNEY INTERNATIONAL REPORTS (2020)
The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury
Qi Peng et al.
KIDNEY INTERNATIONAL (2019)
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies
Denis Glotz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Clinical promise of next-generation complement therapeutics
Dimitrios C. Mastellos et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial
William H. Marks et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
C4d in Native Glomerular Diseases
Preeti Chandra
AMERICAN JOURNAL OF NEPHROLOGY (2019)
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients
Stanley C. Jordan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The lectin pathway in renal disease: old concept and new insights
Mariana Gaya da Costa et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
A prospective randomized, controlled trial of eculizumab to prevent ischemia-reperfusion injury in pediatric kidney transplantation
Michael Kaabak et al.
PEDIATRIC TRANSPLANTATION (2018)
Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejectionresults from a first-in-patient phase 1 trial
F. Eskandary et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Is Early Complement Activation in Renal Transplantation Associated with Later Graft Outcome?
Steffen Bobka et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial
S. Kulkarni et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury
Felix Poppelaars et al.
FASEB JOURNAL (2017)
A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial
Theodoros Kassimatis et al.
TRIALS (2017)
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
R. A. Montgomery et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function
Z. X. Yu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Role of the lectin complement pathway in kidney transplantation
Conrad A. Farrar et al.
IMMUNOBIOLOGY (2016)
Old dogsnew tricks: immunoregulatory properties of C3 and C5 cleavage fragments
Admar Verschoor et al.
IMMUNOLOGICAL REVIEWS (2016)
The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond
Jozsef Dobo et al.
IMMUNOLOGICAL REVIEWS (2016)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
M. Haas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4
Elham Asgari et al.
FASEB JOURNAL (2014)
A Novel Antibody against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin from Blood Samples
Diana Pauly et al.
PLOS ONE (2014)
Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination
G. H. Struijk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Structural and Functional Overview of the Lectin Complement Pathway: Its Molecular Basis and Physiological Implication
Misao Matsushita et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
M. D. Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Emerging role of the mannose-binding lectin-dependent pathway of complement activation in clinical organ transplantation
Stefan P. Berger et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2011)
Systemic Complement Activation in Deceased Donors Is Associated With Acute Rejection After Renal Transplantation in the Recipient
Jeffrey Damman et al.
TRANSPLANTATION (2011)
Therapeutic Targeting of Classical and Lectin Pathways of Complement Protects from Ischemia-Reperfusion-Induced Renal Damage
Giuseppe Castellano et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Complement-Dependent Transport of Antigen into B Cell Follicles
Santiago F. Gonzalez et al.
JOURNAL OF IMMUNOLOGY (2010)
New insights into the molecular mechanisms of classical complement activation
Mihaela Kojouharova et al.
MOLECULAR IMMUNOLOGY (2010)
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
G. Einecke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Identification of the C1q-binding Sites of Human C1r and C1s A REFINED THREE-DIMENSIONAL MODEL OF THE C1 COMPLEX OF COMPLEMENT
Isabelle Bally et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The role of the anaphylatoxins in health and disease
Andreas Klos et al.
MOLECULAR IMMUNOLOGY (2009)
Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor
Felicity K. Kerr et al.
MOLECULAR IMMUNOLOGY (2008)
Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system
Ziyad Al-Aly et al.
TRANSPLANT INTERNATIONAL (2008)
The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies
Ke Li et al.
MOLECULAR IMMUNOLOGY (2007)
Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene
X. Zheng et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Local extravascular pool of C3 is a determinant of postischemic acute renal failure
Conrad A. Farrar et al.
FASEB JOURNAL (2006)
Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo
Meghan E. McMullen et al.
IMMUNOBIOLOGY (2006)
Association between mannose-binding lectin levels and graft survival in kidney transplantation
SP Berger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Structural and functional anatomy of the globular domain of complement protein C1q
W Kishore et al.
IMMUNOLOGY LETTERS (2004)
Pharmacokinetics and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass
JS Li et al.
AMERICAN HEART JOURNAL (2004)
Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination
S Ménoret et al.
TRANSPLANTATION (2004)
Pathogenesis of renal ischemia/reperfusion injury: lessons from knockout mice
YHH Lien et al.
LIFE SCIENCES (2003)
Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition
A Azimzadeh et al.
XENOTRANSPLANTATION (2003)
Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice
JM Thurman et al.
JOURNAL OF IMMUNOLOGY (2003)
Share Paper
